The subgroup with low sEGFR expression, with longer survival between TN tumours, had lower OS than patients with Luminal A (p = 0.0004) and HER2+ (p = 0.0130) tumours, but with no OS difference in relation to patients with luminal B tumours (p = 0.0991). Here, ERBB2 is linked to neoplasm.